Form 4: TransDigm Group Director Valladares Reports Stock Option Grant
SEC Form 4
Director Jorge Valladares reports the grant of stock options in TransDigm Group INC on September 17, 2024.
Summary
- On September 17, 2024, Jorge Valladares, a director of TransDigm Group INC, reported the acquisition of stock options.
- The stock options were granted at various exercise prices and expiration dates.
- Valladares acquired options with exercise prices of $559.78, $284.97, $347.17, $476.81, $560.81, $582.8, and $834.73.
- The expiration dates for these options range from November 5, 2028, to November 2, 2033.
- Some options are held directly, while others are held indirectly through a family trust.
- The total number of options held following the reported transactions is 28,080 directly and 227,700 indirectly.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock option grants, which is neutral in sentiment.
Industry Context
Stock option grants are a common form of executive compensation in publicly traded companies like TransDigm Group, aligning management's interests with those of shareholders.
Comparison to Industry Standards
- Comparing TransDigm's executive compensation structure to companies like Heico Corporation (HEI) or Curtiss-Wright Corporation (CW) would provide a benchmark for assessing the competitiveness and alignment of incentives.
- Analyzing the vesting schedules and performance metrics associated with these options against industry norms can further illuminate the effectiveness of TransDigm's compensation strategy.
- Benchmarking the total number of options granted to Valladares against similar grants to directors at comparable companies can offer insights into the scale of equity-based compensation at TransDigm.
Stakeholder Impact
- The grant of stock options can incentivize the director to act in ways that increase shareholder value.
- Employees may view stock option grants to directors as part of the overall compensation structure within the company.
Key Dates
| Date | Description |
|---|---|
| 09/30/2019 | Date exercisable for some stock options |
| 09/30/2020 | Date exercisable for some stock options |
| 09/30/2021 | Date exercisable for some stock options |
| 09/30/2023 | Date exercisable for some stock options |
| 09/30/2024 | Date exercisable for some stock options |
| 11/08/2027 | Expiration date for some stock options |
| 11/05/2028 | Expiration date for some stock options |
| 04/25/2029 | Expiration date for some stock options |
| 11/15/2029 | Expiration date for some stock options |
| 11/11/2030 | Expiration date for some stock options |
| 11/09/2032 | Expiration date for some stock options |
| 11/02/2033 | Expiration date for some stock options |
| 09/17/2024 | Date of the transaction (stock option grant) |
| 09/18/2024 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.